Home›People›George Siber
GS

George Siber

Board Member at Celestial Therapeutics.

DirectorPublic company
Updated Nov 10, 2026·Latest SEC filing Jul 6, 2026·Suggest an edit

About George Siber

George Siber is a board member at Celestial Therapeutics.

George Siber reports to the SEC as a director of 1 public company: Genocea Biosciences (GNCA).

George Siber first appears on SEC filings in 2014.

Experience

This experience comes from George Siber's profile and from SEC filings. For roles taken from filings, the years are when the filings name George Siber in the role, so the role may have started earlier or lasted longer.

Celestial Therapeutics Inc. Current
Board Member
Member Board of Directors (2024 – Present)
2024 – Present · Irvine, CA
Develops vaccines and treatments for people with infectious diseases, rare diseases and cancers.
Institute of Microbiology, Chinese Academy of Sciences Current
Visiting Researcher
2022 – Present
Clover Biopharmaceuticals Current
Member of SAB
2020 – Present
康希诺生物股份公司 CanSino Biologics Inc. Current
Member of SAB
2020 – Present
ILiAD Biotechnologies Current
Member of SAB
2019 – Present
AdVaccine Current
Member of SAB
2018 – Present
Siber Biotechnologies LLC Current
President
2013 – Present
Johns Hopkins University Current
Adjunct Professor of International Health
2008 – Present
Vaxart
Member of SAB
2020 – 2024
Vaxxinity
Member of SAB
2020 – 2024
Valneva
Member of SAB
2019 – 2024
Genocea Biosciences, Inc.
Executive Director, Chairman of SAB
2007 – 2022 · Public company (GNCA)
Affinivax Inc.
Co-Founder and Member of BOD
2014 – 2022
CureVac
Member of SAB
2015 – 2021
Vaxess Technologies
Member of SAB
2014 – 2021
International Vaccine Institute
Member of Board of Trustees
2014 – 2020
ClearPath Vaccines
Chief Scientific Officer
2014 – 2019
PaxVax, Inc.
Member of SAB
2014 – 2018
ADITEC Vaccine Consortium
Member of Scientific Advisory Committee
2012 – 2016
The Wistar Institute
Member of the Vaccine Center Advisory Board
2012 – 2016

Key Colleagues at Startups

The people George Siber works with at each company, as listed on that company's latest Form D.

Celestial Therapeutics Inc. · Form D/A, Jul 6, 2026
LT
Leontis Teryazos
Executive officer and director
AG
Ajay Gupta
Co-founder, President, Chairman & CEO

Sources

  1. SECCelestial Therapeutics Inc. Form D/A, filed Jul 6, 2026
  2. SECForms 3, 4 and 5 filed by George Siber (SEC filer 1594631)